Global burden of drug-resistant tuberculosis in children: a mathematical modelling study

The Lancet Infectious Diseases

Volumn 16, Issue 10, 2016, Pages 1193-1201

  Dodd, Peter J ^a   Sismanidis, Charalambos ^b   Seddon, James A ^c  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TUBERCULOSTATIC AGENT;

AFRICA; ARTICLE; BAYES THEOREM; CHILD; DRUG RESISTANT TUBERCULOSIS; EASTERN EUROPE; EUROPE; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; HUMAN; INCIDENCE; MATHEMATICAL MODEL; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PACIFIC ISLANDS; PREVALENCE; PRIORITY JOURNAL; SOUTHEAST ASIA; GLOBAL HEALTH; ISOLATION AND PURIFICATION; PRESCHOOL CHILD; THEORETICAL MODEL; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; GLOBAL HEALTH; HUMANS; INCIDENCE; ISONIAZID; MODELS, THEORETICAL; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84990060549     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(16)30132-3     Document Type: Article

References (21)

1. 1 Seddon, JA, Jenkins, HE, Liu, L, et al. Counting children with tuberculosis: why numbers matter. Int J Tuberc Lung Dis 19:suppl 1 (2015), 9–16.
2. 2 Dodd, PJ, Gardiner, E, Coghlan, R, Seddon, JA, Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study. Lancet Glob Health 2 (2014), e453–e459.
3. 3 Jenkins, HE, Tolman, AW, Yuen, CM, et al. Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates. Lancet 383 (2014), 1572–1579.
4. 4 WHO. Global tuberculosis control 2015, 2015, World Health Organization, Geneva.
5. 5 Marais, BJ, Gie, RP, Schaaf, HS, et al. The clinical epidemiology of childhood pulmonary tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 8 (2004), 278–285.
6. 6 Marais, BJ, Gie, RP, Schaaf, HS, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 8 (2004), 392–402.
7. 7 WHO. Guidance for national tuberculosis programmes on the management of tuberculosis in children, 2014, World Health Organization, Geneva (cited Jan 29, 2016) http://apps.who.int/iris/handle/10665/112360.
8. 8 Smieja, MJ, Marchetti, CA, Cook, DJ, Smaill, FM, Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev, 2, 2000 CD001363.
9. 9 Zar, HJ, Cotton, MF, Strauss, S, et al. Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial. BMJ, 334, 2007, 136.
10. 10 Moore, BK, Anyalechi, E, van der Walt, M, et al. Epidemiology of drug-resistant tuberculosis among children and adolescents in South Africa, 2005–10. Int J Tuberc Lung Dis 19 (2015), 663–669.
11. 11 Dye, C, Glaziou, P, Floyd, K, Raviglione, M, Prospects for tuberculosis elimination. Annu Rev Public Health 34 (2013), 271–286.
12. 12 Seddon, JA, Fred, D, Amanullah, F, et al. Post-exposure management of multidrug-resistant tuberculosis contacts: evidence-based recommendations. Policy brief no. 1, 2015, Harvard Medical School Center for Global Health Delivery; Dubai, Dubai, United Arab Emirates.
13. 13 Schaaf, HS, Gie, RP, Kennedy, M, Beyers, N, Hesseling, PB, Donald, PR, Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30-month follow-up. Pediatrics 109 (2002), 765–771.
14. 14 Schaaf, HS, Van Rie, A, Gie, RP, et al. Transmission of multidrug-resistant tuberculosis. Pediatr Infect Dis J 19 (2000), 695–700.
15. 15 Yuen, CM, Jenkins, HE, Rodriguez, CA, Keshavjee, S, Becerra, MC, Global and regional burden of isoniazid-resistant tuberculosis. Pediatrics 136 (2015), e50–e59.
16. 16 Zignol, M, Sismanidis, C, Falzon, D, Glaziou, P, Dara, M, Floyd, K, Multidrug-resistant tuberculosis in children: evidence from global surveillance. Eur Respir J 42 (2013), 701–707.
17. 17 WHO. Guidelines for surveillance of drug resistance in tuberculosis, 5th edn., 2015, World Health Organization, Geneva http://www.who.int/tb/publications/2015/drs_guidelines/en/ (accessed Jan 29, 2016).
18. 18 Glaziou, P, Sismanidis, C, Pretorius, C, Timimi, H, Floyd, K, Global TB Report 2015: Technical appendix on methods used to estimate the global burden of disease caused by TB, 2015, World Health Organization, Geneva.
19. 19 Gastner, MT, Newman, MEJ, Diffusion-based method for producing density-equalizing maps. Proc Natl Acad Sci USA 101 (2004), 7499–7504.
20. 20 Harausz, E, Garcia-Prats, AJ, Schaaf, HS, et al. Global treatment outcomes in children with paediatric MDR-TB: systematic review and meta-analysis. Int J Tuberc Lung Dis, 19(suppl 2), 2015, S29.
21. 21 Harvard Medical School Center for Global Health Delivery–Dubai. Global consultation on best practices in the delivery of preventive therapy for household contacts of patients with drug-resistant tuberculosis. Proceedings of the Harvard Medical School Center for Global Health Delivery–Dubai, 1, 2015, 1.